Longevity maximalist currently building rejuvenating gene therapies based on in vivo partial cellular reprogramming with Yamanaka factors.
General Partner @ Alix Ventures: Supporting Early Stage Life Science Startups Engineering Biology to Drive Radical Advances in Human Health 🚀
KdT is the standard for early-stage science venture investing. We help founders and their companies re-architect the world at a molecular level.
Text to speech